NeuroBo Pharmaceuticals, Inc. Stock News

NeuroBo Pharmaceuticals Inc (NRBO) shares closed today 12.8% lower than it did at the end of yesterday. The stock is currently down 75.2% year-to-date, down 77.4% over the past 12 months, and down 84.2% over the past five years. Today, the Dow Jones Industrial Average rose 0.3%, and the S&P 500 fell 0.1%. Trading Activity Shares traded as high as $1.58 and as low as $1.28 this week.Shares closed 82.9% below its 52-week high and 1.6% above its 52-week low.Trading volume this week was 51.3% lower than the 10-day average and 57.0% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 153.1% The company's stock price performance over the past 12 months lags the peer average by 147.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Are these penny stocks on your watchlist right now? The post Best Penny Stocks to Buy Right Now?

The stock price of Neurobo Pharmaceuticals Inc (NASDAQ: NRBO) increased by over 6% yesterday. This is why it happened.

There's loads of hot penny stocks worth checking in on today and we're taking a look at what some of the top movers are doing! The post Hot Penny Stocks: Why NEW, ARDX, WTRH, GSAT and NRBO Are Moving

BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying ther

This sector is always a risky area to gamble in. If you have the stomach for it, however, these biotech stocks could see massive gains.

Are these the best biotech penny stocks to watch in 2021? The post 3 Biotech Penny Stocks That You Need to Know About In 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | Penny

Life Clips (LCLP) stock is falling on Tuesday following an update from the battery company about its recent business announcements. The post LCLP Stock: 10 Reasons Why Penny Stock Battery Maker Life C

Neurobo Pharmaceuticals (NRBO) stock is on the rise Tuesday as retail traders take a liking to the biotechnology company. The post NRBO Stock: 6 Things to Know About NeuroBo Pharma as Retail Investors

The stock price of Neurobo Pharmaceuticals Inc (NASDAQ: NRBO) increased by over 30% pre-market. These are some details you should know.

The stock price of Neurobo Pharmaceuticals Inc (NASDAQ: NRBO) increased by over 35% during intraday trading. This is why it happened.

BOSTON, May 17, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therap

BOSTON, April 15, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying ther

Wall Street recommends buying shares of NeuroBo Pharmaceuticals Inc (NASDAQ:NRBO) and Windtree Therapeutics Inc (NASDAQ:WINT), even though these two securities have shown poor performance over the pri

The stock price of NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO) increased by over 5% pre-market. This is why it happened.